January 2027
CFP closes 1 Jan
International Conference on Law, Ethics & Biotechnology Regulation
ICLEBR 2027
International Conference on Law, Ethics & Biotechnology Regulation is a 2-day event in Frankfurt, Germany on 28–29 January 2027, organized by World Research Association for Education and Science. Abstracts are due by 1 January 2027. Its call for papers covers Biotechnology Law, Biotechnology Regulation and Bioethics, among other areas. World Research Association for Education and Science has 389 other upcoming conferences listed here.
Important dates
-
Abstract / full paper deadline
In 46 days
-
Conference
Frankfurt, Germany
All deadlines are as published by the organizer. Check the official website for the time zone.
About this conference
International Conference on Law, Ethics & Biotechnology Regulation ICLEBR, organized by World Research Association for Education and Science, is a leading international conference that connects researchers, engineers, healthcare professionals, academicians, scientists, industry experts, and professionals from around the world. The conference provides a global platform to share groundbreaking research, discuss emerging developments, showcase innovative ideas, and build meaningful professional collaborations. By bringing together diverse academic and professional communities, International Conference on Law, Ethics & Biotechnology Regulation ICLEBR aims to promote knowledge exchange, interdisciplinary collaboration, innovation, and the advancement of research on a global scale.
Topics and scope
- Biotechnology Law
- Biotechnology Regulation
- Bioethics
- Biotechnology Ethics
- Life Sciences Law
- Health Law
- Medical Law
- Biomedical Regulation
- Global Biotechnology Governance
- Biotechnology Policy
- Regulatory Innovation
- Regulatory Harmonization
- International Biotechnology Law
- Comparative Biotechnology Law
- Cross-Border Biotechnology
- Transnational Regulation
- Emerging Technology Law
- Responsible Biotechnology
- Responsible Innovation
- Ethical Biotechnology
- Human Genome Editing
- Gene Editing Regulation
- CRISPR Governance
- CRISPR Ethics
- Gene Therapy Law
- Gene Therapy Regulation
- Cell Therapy Regulation
- Cell-Based Therapies
- Advanced Therapies
- Regenerative Medicine Law
- Stem Cell Regulation
- Stem Cell Ethics
- Germline Editing
- Heritable Genome Editing
- Somatic Genome Editing
- Genome Editing Oversight
- Genomic Governance
- Genomic Privacy
- Genetic Data Protection
- Genetic Discrimination
- Genetic Testing Regulation
- Genetic Counseling Ethics
- Genomic Medicine
- Precision Medicine Regulation
- Personalized Medicine Law
- Genomic Research Ethics
- Human Genetics Law
- Human Subject Research
- Clinical Trial Regulation
- Clinical Research Ethics
- Informed Consent
- Research Participant Rights
- Research Ethics Committees
- Institutional Review Boards
- Research Integrity
- Scientific Integrity
- Research Misconduct
- Biomedical Research Governance
- Biotechnology Clinical Trials
- Experimental Therapies
- Unproven Therapies
- Medical Travel Regulation
- Rogue Biotechnology Clinics
- Patient Safety
- Patient Autonomy
- Patient Rights
- Human Dignity
- Reproductive Ethics
- Reproductive Biotechnology
- Assisted Reproduction
- Embryo Research
- Embryo Protection
- Prenatal Genetic Testing
- Preimplantation Genetic Testing
- Human Enhancement
- Enhancement Ethics
- Designer Babies
- Genetic Enhancement
- Transhumanism and Law
- Biotechnology and Human Rights
- Genetics and Human Rights
- Right to Health
- Right to Privacy
- Equality and Biotechnology
- Biotechnology and Social Justice
- Genetic Justice
- Intergenerational Justice
- Disability and Genetics
- Disability Rights
- Eugenics and Biotechnology
- Genetic Equity
- Access to Biotechnology
- Global Health Equity
- Biotechnology and Developing Countries
- Technology Access
- Biotechnology Capacity Building
- Synthetic Biology Law
- Synthetic Biology Ethics
- Synthetic Biology Governance
- Bioengineering Regulation
- Engineered Organisms
- Gene Drives
- Gene Drive Governance
- Genetically Modified Organisms
- GMO Regulation
- GMO Biosafety
- Agricultural Biotechnology
- Agricultural Genetic Engineering
- Food Biotechnology
- Food Safety Regulation
- Genetically Modified Foods
- Novel Foods Regulation
- Environmental Biotechnology
- Environmental Biosafety
- Biotechnology and Biodiversity
- Genetic Resources
- Biodiversity Governance
- Digital Sequence Information
- Genetic Resource Access
- Benefit Sharing
- Nagoya Protocol
- Traditional Knowledge
- Indigenous Knowledge
- Indigenous Genetic Resources
- Biocultural Rights
- Traditional Medicine
- Ethnobiology and Law
- Biobanking Regulation
- Biobank Governance
- Biological Samples
- Human Tissue Regulation
- Tissue Ownership
- Biological Material Rights
- Biospecimen Governance
- Biobank Consent
- Data Governance
- Health Data Regulation
- Genomic Data Governance
- Genetic Data Ownership
- Data Sovereignty
- Indigenous Data Sovereignty
- Data Sharing
- Cross-Border Data
- Genomic Data Sharing
- Privacy and Genomics
- Cybersecurity and Biotechnology
- Biomedical Cybersecurity
- Biotechnology Data Security
- Artificial Intelligence and Biotechnology
- AI in Biotechnology
- AI and Genomics
- AI Drug Discovery
- AI Biotechnology Regulation
- AI Research Ethics
- Algorithmic Genomics
- Machine Learning and Genetics
- Synthetic Data and Genomics
- Digital Biology
- Computational Biology Regulation
- Bioinformatics Governance
- Biotechnology Intellectual Property
- Biotechnology Patents
- Genetic Patents
- Gene Editing Patents
- Genomic Patents
- Pharmaceutical Patents
- Patentability of Biotechnology
- Patent Ethics
- Patent Ownership
- Biotechnology Licensing
- Technology Transfer
- Biotechnology Commercialization
- University Biotechnology
- Research Commercialization
- Open Biotechnology
- Open Science and Biotechnology
- Access to Knowledge
- Trade Secrets and Biotechnology
- Biotechnology Competition Law
- Antitrust and Life Sciences
- Pharmaceutical Regulation
- Biopharmaceutical Law
- Biosimilar Regulation
- Vaccine Regulation
- Vaccine Innovation
- Vaccine Equity
- Pharmaceutical Innovation
- Drug Development Regulation
- Drug Safety
- Pharmacovigilance
- Biologics Regulation
- Biotherapeutics Regulation
- Biological Product Standards
- Cell and Gene Therapy Products
- Quality and Safety Regulation
- Manufacturing Standards
- Regulatory Science
- Regulatory Reliance
- Regulatory Cooperation
- International Regulatory Convergence
Call for papers
Abstracts are due by 1 January 2027. Submission details are on the official website.
Where this information comes from
- Source
- Submitted by the organizer
- Listed on
- 19 October 2026
- Verification
- Reviewed by an editor before publishing
- Reference
- FCA2896083
Questions about ICLEBR 2027
When and where is ICLEBR 2027?
28–29 January 2027 in Frankfurt, Germany.
Can I attend online?
This listing does not confirm an online option. Check the official website.
What is the submission deadline?
Abstracts are due by 1 January 2027.
How do I register?
Registration and fees are handled by the organizer on the official website.
Verify that you represent this event.
Tell us what needs to be reviewed.